PeptideStack
5.2kquestions
20kanswers
220users

How would I detect aggregation in a cagrilintide vial without sending it to PeptideMeter?

Asked 15 Jun 2025Modified 12 months agoViewed 30k times
This question was closed as primarily opinion-based.Closed 11 Jul 2025. Answers already posted are preserved; new answers are not accepted. Questions here need a factual basis on which they can be answered.
34

Setup, so nobody has to ask: aggregation · cagrilintide · PeptideMeter.

Everything I have found on this is either a forum aside or a product page, neither of which I trust.

I am comfortable with the arithmetic; what I am missing is the procedural detail around it.

What is the correct sequence, and where is the step that people usually skip?

vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
shareeditfollowflag
DV
askedDr_Ilse_Vandenberg78k24815 Jun 2025

2 Answers

Accepted answer first, then by votes
66

Accepted answer

The relevant detail is that rounding to the nearest whole syringe unit is usually the right error to make, but understanding which direction it is and why matters.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and condensation on a cold barrel makes it harder to read the meniscus.

Mechanically, breaking it down further: if a 10 mg vial has 96.5 per cent content, you have 9.65 mg of peptide. Divide that by 2.00 mL and your concentration is 4.825 mg/mL, not 5.00 mg/mL, which is a 3.5 per cent systematic error in every dose calculation.

The Arrhenius relationship for drawing kinetics means that cold solution takes noticeably longer to draw than room-temperature solution.

I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.

Do the arithmetic twice, ideally with someone else doing it independently.

edited 14 Aug 2025 by nkem_obiora — added the citation requested in comments

shareimprove this answerflag
NO
answered · acceptednkem_obiora46k383 Aug 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
25

Specifically, write the units at every step, because units errors are the failure mode that catches everyone eventually.

Worked example, because the general form is easier to trust once you have seen it once. Take a 10 mg vial and add 2 mL of diluent: the concentration is 10 ÷ 2 = 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL. On a U-100 syringe, where 1 unit = 0.01 mL, that is 0.1 ÷ 0.01 = 10 units. Change the diluent to 1 mL and the same dose becomes 5 units — same dose, half the resolution.

To be exact about it, number of stopper piercings matters less than the gauge doing the piercing. A 30G or 31G needle through a butyl stopper leaves a track that reseals; a 21G or 18G drawing needle punches a core and can drop it into the solution.

The content assay results from major testing services show that nominal vial claim and measured content differ by one to ten per cent, making content a driver of dose error.

If in doubt, use more diluent and accept the shorter usable window.

shareimprove this answerflag
GS
answeredgradient_slope41k3814 Aug 2025
6Minor: the trial name is hyphenated in the original publication. – ivo_paunovic 10 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.